Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation (ASCT) in previously untreated patients with peripheral T-cell lymphoma (PTCL). Results of a prospective phase II study from the GELCAB.

被引：6

作者：

Lopez-Guillermo, A ^{[1
]}

Mercadal, S ^{[1
]}

Briones, J ^{[1
]}

Xicoy, B ^{[1
]}

Pedro, C ^{[1
]}

Escoda, L ^{[1
]}

Estany, C ^{[1
]}

Camos, M ^{[1
]}

Ribera, JM ^{[1
]}

Martino, R ^{[1
]}

Montserrat, E ^{[1
]}

机构：

[1] GELCAB, Grp Estudi Limformes Catalunya & Balears, Barcelona, Spain

来源：

BLOOD | 2005年 / 106卷 / 11期

关键词：

D O I：

10.1182/blood.V106.11.2077.2077

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2077

引用

页码：587A / 588A

页数：2

共 50 条

[21] Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma.
Khan, Niloufer
Khimani, Farhad
Shustov, Andrei R.
Shadman, Mazyar
Ruan, Jia
Moskowitz, Alison J.
Straus, David J.
Kumar, Anita
Sauter, Craig Steven
Zelenetz, Andrew David
Noy, Ariela
Shah, Gunjan L.
Matasar, Matthew J.
Drullinsky, Pamela
Hamilton, Audrey M.
Drill, Esther N.
Van Besien, Koen
Giralt, Sergio
Horwitz, Steven M.
Dahi, Parastoo
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[22] Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation
C. Kahl
M. Leithäuser
D. Wolff
B. Steiner
G. Hartung
J. Casper
M. Freund
Annals of Hematology, 2002, 81 : 646 - 650
[23] Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation
Kahl, C
Leithäuser, M
Wolff, D
Steiner, B
Hartung, G
Casper, J
Freund, M
ANNALS OF HEMATOLOGY, 2002, 81 (11) : 646 - 650
[24] Multicenter phase II study of romidepsin plus lenalidomide for patients with previously untreated peripheral T-cell lymphoma (PTCL).
Ruan, Jia
Zain, Jasmine M.
Palmer, Brett
Jovanovic, Borko
Mi, Xinlei
Swaroop, Alok
Winter, Jane
Gordon, Leo I.
Karmali, Reem
Pro, Barbara
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[25] High-dose chemotherapy followed by autologous stem-cell transplantation for Hodgkin disease using CVB as conditioning regimen
Avila, R. A.
Valdez, J. A.
Caeiro, G.
Basquiera, A. L.
Sturich, A. G.
Berretta, A. R.
Garcia, J. J.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[26] The role of high dose chemotherapy and autologous stem-cell transplantation in peripheral T-cell lymphoma: A review of the literature and new perspectives
Yared, Jean
Kimball, Amy
CANCER TREATMENT REVIEWS, 2013, 39 (01) : 51 - 59
[27] A Phase 1b/2 Study of Chidamide Combined with CHOP in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL)
Shi, Yuankai
Gui, Lin
Cao, Junning
Zhang, Huilai
Zhu, Jun
Ji, Dongmei
Fan, Qian
Song, Yuqin
Shen, Weina
Bai, Guiying
Han, Ming-Zhe
Jiang, Shiyu
BLOOD, 2019, 134
[28] HIGH-DOSE THERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA
KESSINGER, A
ARMITAGE, JO
SMITH, DM
LANDMARK, JD
BIERMAN, PJ
WEISENBURGER, DD
BLOOD, 1989, 74 (04) : 1260 - 1265
[29] Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma
Thieblemont, C
Antal, D
Lacotte-Thierry, L
Delwail, V
Espinouse, D
Michallet, AS
Traulle, C
Bouafia-Sauvy, F
Giraud, C
Salles, G
Guilhot, F
Coiffier, B
CANCER, 2005, 104 (07) : 1434 - 1441
[30] High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival
Min Kyoung Kim
Shin Kim
Sung Sook Lee
Sun Jin Sym
Dae Ho Lee
Seongsoo Jang
Chan Jeong Park
Hyun Sook Chi
Jooryung Huh
Cheolwon Suh
Annals of Hematology, 2007, 86 : 435 - 442

← 1 2 3 4 5 →